Stereotactic Microwave Ablation of Hepatocellular Carcinoma: The Impact of Tumor Size and Minimal Ablative Margin on Therapeutic Success
Abstract
Share and Cite
Pausch, A.-M.; Ghali, T.; Wertheimer, T.; Zeman, F.; Mueller, K.; Doppler, M.C.; Einspieler, I.; Beyer, L.P.; Schleder, S.; Stroszczynski, C.; et al. Stereotactic Microwave Ablation of Hepatocellular Carcinoma: The Impact of Tumor Size and Minimal Ablative Margin on Therapeutic Success. Tomography 2023, 9, 50-59. https://doi.org/10.3390/tomography9010005
Pausch A-M, Ghali T, Wertheimer T, Zeman F, Mueller K, Doppler MC, Einspieler I, Beyer LP, Schleder S, Stroszczynski C, et al. Stereotactic Microwave Ablation of Hepatocellular Carcinoma: The Impact of Tumor Size and Minimal Ablative Margin on Therapeutic Success. Tomography. 2023; 9(1):50-59. https://doi.org/10.3390/tomography9010005
Chicago/Turabian StylePausch, Antonia-Maria, Tamam Ghali, Tobias Wertheimer, Florian Zeman, Karolina Mueller, Michael Christian Doppler, Ingo Einspieler, Lukas Philipp Beyer, Stephan Schleder, Christian Stroszczynski, and et al. 2023. "Stereotactic Microwave Ablation of Hepatocellular Carcinoma: The Impact of Tumor Size and Minimal Ablative Margin on Therapeutic Success" Tomography 9, no. 1: 50-59. https://doi.org/10.3390/tomography9010005
APA StylePausch, A.-M., Ghali, T., Wertheimer, T., Zeman, F., Mueller, K., Doppler, M. C., Einspieler, I., Beyer, L. P., Schleder, S., Stroszczynski, C., & Luerken, L. (2023). Stereotactic Microwave Ablation of Hepatocellular Carcinoma: The Impact of Tumor Size and Minimal Ablative Margin on Therapeutic Success. Tomography, 9(1), 50-59. https://doi.org/10.3390/tomography9010005